Singh Biotechnology
Bd Singh Biotechnology Pdf Singh biotechnology (sbt) is a biotechnology organization that is in the business of discovering and developing unique and propriety therapeutic agents for the treatment of a variety of diseases (cancers, autoimmune, and ophthalmologic diseases) by leveraging our novel technology platform. Singh biotechnology is a seed company based in tampa (united states), founded in 2014 by sunanda singh. it operates as a biotechnology firm pioneering single domain antibody therapeutics for cancers and autoimmune diseases. singh biotechnology has raised $225k in funding.
Singh Biotechnology View sunanda singh, md, phd’s profile on linkedin, a professional community of 1 billion members. Find company research, competitor information, contact details & financial data for singh biotechnology, llc of brooksville, fl. get the latest business insights from dun & bradstreet. Singh biotechnology is a biotechnology organization that develops therapeutic agents for the treatment of cancers and autoimmune diseases. About: singh biotechnology (sbt) is a biotechnology organization that is in the business of discovering and developing unique and propriety therapeutic agents for the treatment of a variety of diseases (cancers, autoimmune, and ophthalmologic diseases) by leveraging our novel technology platform.
Singh Biotechnology Singh biotechnology is a biotechnology organization that develops therapeutic agents for the treatment of cancers and autoimmune diseases. About: singh biotechnology (sbt) is a biotechnology organization that is in the business of discovering and developing unique and propriety therapeutic agents for the treatment of a variety of diseases (cancers, autoimmune, and ophthalmologic diseases) by leveraging our novel technology platform. Founded by dr. sunanda singh, m.d., ph.d., the company has developed a proprietary class of cell penetrating nano antibodies that are capable of entering the cell and acting directly on intracellular proteins, offering a potential solution to diseases previously labeled ‘undruggable.’. Find contact information for singh biotechnology. learn about their business services, research & development market share, competitors, and singh biotechnology's email format. At singh biotechnology we use our novel proprietary disruptive technology single domain antibody (sdab) platform to create miniature antibodies that comprise solely of the variable region and therefore the sdab is devoid of light chains. Singh biotechnology (sbt) is a biotechnology organization that is in the business of discovering and developing unique and propriety therapeutic agents for the treatment of a variety of diseases (cancers, autoimmune, and ophthalmologic diseases) by leveraging our novel technology platform.
Singh Biotechnology Founded by dr. sunanda singh, m.d., ph.d., the company has developed a proprietary class of cell penetrating nano antibodies that are capable of entering the cell and acting directly on intracellular proteins, offering a potential solution to diseases previously labeled ‘undruggable.’. Find contact information for singh biotechnology. learn about their business services, research & development market share, competitors, and singh biotechnology's email format. At singh biotechnology we use our novel proprietary disruptive technology single domain antibody (sdab) platform to create miniature antibodies that comprise solely of the variable region and therefore the sdab is devoid of light chains. Singh biotechnology (sbt) is a biotechnology organization that is in the business of discovering and developing unique and propriety therapeutic agents for the treatment of a variety of diseases (cancers, autoimmune, and ophthalmologic diseases) by leveraging our novel technology platform.
Singh Biotechnology At singh biotechnology we use our novel proprietary disruptive technology single domain antibody (sdab) platform to create miniature antibodies that comprise solely of the variable region and therefore the sdab is devoid of light chains. Singh biotechnology (sbt) is a biotechnology organization that is in the business of discovering and developing unique and propriety therapeutic agents for the treatment of a variety of diseases (cancers, autoimmune, and ophthalmologic diseases) by leveraging our novel technology platform.
Singh Biotechnology
Comments are closed.